Contact Us
Drug Search Results
More Filters [+]

Sodium iodide (131i)

Alternative Names: sodium iodide (131i), Sodium Iodide I131, I131, i-131, megatope, iodotope, sodium iodide i 131, hicon, volumex, theracap, robengatope
Latest Update: 2024-12-02
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous,Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Australia | Austria | Belgium | Bulgaria | Canada | Colombia | Cyprus | Denmark | Dominican Republic | Germany | Hong Kong | Hungary | India | Indonesia | Ireland | Italy | Korea | Malaysia | Norway | Poland | Portugal | Singapore | Slovenia | South Africa | Spain | Sweden | Taiwan | Turkey | United Kingdom | United States | Vietnam

Approved Indications: Hyperthyroidism | Oncology Unspecified

Known Adverse Events: Tachycardia | Depressive Disorder | Chest Pain | Pain Unspecified | Sialadenitis | Hypoparathyroidism | Hyperthyroidism | Hypothyroidism | Thyroid Crisis | Anemia | Thrombocytopenia | Congenital Hypothyroidism | Skin Abnormalities | Leukemia | Bone Cancer | Parathyroid Cancer | Salivary Gland Cancer | Skin Cancer | Thyroid Cancer | Oncology Unspecified | Pulmonary Edema | Pulmonary Fibrosis | Radiation Pneumonitis | Edema

Company: Cellectar Biosciences
Company Location: FLORHAM PARK NJ 07932
Company CEO: JAMES V. CARUSO
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Sodium iodide (131i)

Countries in Clinic: Canada, United States

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Prostate Cancer

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
ARROW

P2

Active, not recruiting

Prostate Cancer

2023-09-21

57%

Recent News Events

Date

Type

Title

11/12/2024

News Article

 Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of Cancer

11/07/2024

News Article

 Cellectar Selected to Present New Data from Phase 2 CLOVER-WaM Study in Oral Session at ASH 2024

09/04/2024

News Article

 International Isotopes Inc. and Phantech Medical Launch PhanQual to Revolutionize Calibration Sources for Pre-Clinical Imaging

09/03/2024

News Article

 Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions